Elkon K, Weissbach H, Brot N
Hospital for Special Surgery, Cornell University Medical College, New York, NY 10021.
Neurochem Res. 1990 Apr;15(4):401-6. doi: 10.1007/BF00969925.
Autoantibodies to three eukaryotic 60S ribosomal phosphoproteins P0, P1 and P2 have been found in the sera of 10-20% of patients with systemic lupus erythematosus (SLE). These antibodies inhibit protein synthesis in vitro and when microinjected into cultured human fibroblasts. The three proteins share a common epitope contained within the carboxyl terminal 22 amino acids of each protein. Because a significant number of SLE patients have central nervous system disturbances with major behavioral disorders, the antiribosomal protein autoantibodies were measured in this subset of SLE individuals to determine whether or not there was an association. These antibodies are present in 90% of SLE patients who were diagnosed as having psychosis, secondary to the disease.
在10%-20%的系统性红斑狼疮(SLE)患者血清中发现了针对三种真核生物60S核糖体磷蛋白P0、P1和P2的自身抗体。这些抗体在体外以及显微注射到培养的人成纤维细胞中时会抑制蛋白质合成。这三种蛋白质在每种蛋白质羧基末端的22个氨基酸中含有一个共同表位。由于相当数量的SLE患者存在伴有严重行为障碍的中枢神经系统紊乱,因此对这一SLE患者亚组进行了抗核糖体蛋白自身抗体检测,以确定是否存在关联。在90%被诊断患有继发于该疾病的精神病的SLE患者中存在这些抗体。